NEUP

Neuphoria Therapeutics Inc.

Healthcare · Biotechnology

$222.14 sample

+2.89 (+1.32%) 1D

Market cap

$246.9B

Price as of

2026-10-03

Latest filing

8-K · 2026-08-21

Alerts

8

Price$222.14 +12.66% 3M daily closessample

222.14195.01

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 23INSInsider sell: Director
Sep 15INSInsider sell: Chief Financial Officer
Sep 04INSInsider sell: Chief Financial Officer
Sep 01INSInsider sell: General Counsel
Aug 21SEC10-Q filed
Aug 12INSInsider buy: Chief Financial Officer
Aug 05INSInsider buy: Chief Executive Officer
Jul 28SECDEF 14A filed

Sign up to see the real NEUP record →

Company facts

SEC EDGAR registration

Name: Neuphoria Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -6sample, -100 to +100
Reporting currency: USD

Who is positioning in NEUP

sample

Insiders: 20 insider transactions over 90 days, net selling, $540.2M
Congress: 5 members traded over 90 days
Institutions · 13F: 42 funds hold $5.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$9.5B +12.8% y/y

Q4 2024Q3 2026

Inventory$5.5B +5.4% y/y

Q4 2024Q3 2026

Accounts receivable$4.1B +13.0% y/y

Q4 2024Q3 2026

Total debt$10.9B +7.3% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $183.9B +12.0% 3M
Sample peer B: $122.6B -4.8% 3M
Sample peer C: $77.6B -10.1% 3M
Sample peer D: $63.7B +1.0% 3M
Sample peer E: $162.7B +10.3% 3M